CMA lawyer: Pfizer and Flynn prices rocketed
A barrister representing the UK’s Competition and Markets Authority today said the enforcer can prove Pfizer and Flynn acted illegally in raising the price of phenytoin capsules by looking at “dramatic” increase in prices after 2012 – and said the conduct is also illegal under the classic United Brands test.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.